APA (7th ed.) Citation

QJ, E., KL, E., DC, Y., & JT, Z. (2021). State of the art in cystic fibrosis pharmacology optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: III. Executive summary. Pediatric pulmonology, 56(7), 1825. https://doi.org/10.1002/ppul.25353

Chicago Style (17th ed.) Citation

QJ, Epps, Epps KL, Young DC, and Zobell JT. "State of the Art in Cystic Fibrosis Pharmacology Optimization of Antimicrobials in the Treatment of Cystic Fibrosis Pulmonary Exacerbations: III. Executive Summary." Pediatric Pulmonology 56, no. 7 (2021): 1825. https://doi.org/10.1002/ppul.25353.

MLA (9th ed.) Citation

QJ, Epps, et al. "State of the Art in Cystic Fibrosis Pharmacology Optimization of Antimicrobials in the Treatment of Cystic Fibrosis Pulmonary Exacerbations: III. Executive Summary." Pediatric Pulmonology, vol. 56, no. 7, 2021, p. 1825, https://doi.org/10.1002/ppul.25353.